Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

Published:2022-02-05 Issue:4 Volume:57 Page:678-680
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Piemontese Simona^ORCID,Lazzari Lorenzo,Ruggeri Annalisa,Marcatti Magda,Lupo Stanghellini Maria Teresa^ORCID,Giglio Fabio,Greco Raffaella^ORCID,Lorentino Francesca,Clerici Daniela,Assanelli Andrea,Farina Francesca,Mastaglio Sara^ORCID,Xue Elisabetta,Marktel Sarah,Vago Luca^ORCID,Gentner Bernhard,Secco Chiara,Corti Consuelo,Carrabba Matteo Giovanni,Bernardi Massimo^ORCID,Peccatori Jacopo,Ciceri Fabio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01600-1.pdf

Reference12 articles.

1. Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32:2541–52.

2. Danylesko I, Shimoni A, Nagler A. Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike. Bone Marrow Transplant. 2012;47:5–14.

3. Michallet M, Sobh M, Milpied N, Bay J-O, Fürst S, Harousseau J-L, et al. Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor. Ann Hematol. 2012;91:1289–97.

4. Shimoni A, Labopin M, Savani B, Hamladji R-M, Beelen D, Mufti G, et al. Intravenous busulfan compared with treosulfan-based conditioning for allogeneic stem cell transplantation in acute myeloid leukemia: a study on behalf of the acute leukemia working party of European Society for blood and marrow transplantation. Biol Blood Marrow Transpl. 2018;24:751–7.

5. Beelen DW, Iacobelli S, Koster L, Eikema D-J, van Biezen A, Stoelzeet F, et al. Comparison of a New reduced toxicity myeloablative treosulfan and fludarabine preparative regimen with myeloablative busulfan or melphalan in combination with fludarabine in older patients with acute myeloid leukemia or myelodysplastic syndromes: a retrospective matched pair analysis of patients from a prospective randomized trial and the European Blood and Marrow Transplantation Society Registry. Blood. 2019;134:3326.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

2. Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT;HemaSphere;2023-09-20

3. Sulfated Polysaccharide Regulates the Homing of HSPCs in a BMP‐2‐Triggered In Vivo Osteo‐Organoid;Advanced Science;2023-06-25

4. Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies;Leukemia Research;2023-04